Irritable Bowel Syndrome: Cases for Clinical Decision-Making

This course applies the new AGA guidelines to four patient cases. Learn to manage IBS-C and IBS-D with medications, lifestyle changes, and natural therapies, as well as how to manage it when there are concomitant mental health concerns.

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. Apply the American Gastroenterological Association’s (AGA) clinical updates for management of irritable
bowel syndrome (IBS) and chronic gastrointestinal pain in disorders of gut-brain interaction
2. Collaborate with patients and providers to develop realistic goals of therapy for patients with IBS
3. Develop a care plan for IBS based on patient-specific factors, including mental health disorders

Gregory M. Zumach, PharmD, BCPS
Clinical Assistant Professor
Oregon State University College of Pharmacy

Dr. Zumach has no relevant financial relationships with ineligible companies to disclose.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: December 1, 2022
Planned Expiration Date: December 1, 2025

Universal Activity Number (UAN): 0107-0000-22-429-H01-P

Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information

Duration	1h 0m
Topic Designator	Disease State/Drug Therapy
ACPE	Yes
ACPE Topic	01 Drug Therapy
Role	Pharmacist
Media-Type	On-Demand
Release Date	12/1/22
CEUs	0.1
Rating	4
ACPE Number	0107-0000-22-429-H01-P